CROLIUS CLAYTON (Chief Financial Officer) sold 27.3% of their position (11.63K shares) of DNA X, INC. on the open market
Open‑market sale worth $16.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/25/2025ACC: 0001641172-25-006117
Officer· Chief Financial Officer
Since Jul 2022
-11.63K
Net shares
Net seller
$16.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.63K
Price / share
$1.45
Trade value
$16.87K
% of position
27.3%
4/23/2025
42.59K→30.96K
Total
Net shares
−11.63K
Net value
-$16.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/23/2025 | S · Sale | −11.63K | $1.45 | $16.87K | 27.3% | 42.59K | 30.96K |
| Total | −11.63K | -$16.87K | ||||||
Derivative Transactions0
No derivative transactions reported